Your browser doesn't support javascript.
loading
Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling.
Sandercock, Alan M; Rust, Steven; Guillard, Sandrine; Sachsenmeier, Kris F; Holoweckyj, Nick; Hay, Carl; Flynn, Matt; Huang, Qihui; Yan, Kuan; Herpers, Bram; Price, Leo S; Soden, Jo; Freeth, Jim; Jermutus, Lutz; Hollingsworth, Robert; Minter, Ralph.
Afiliación
  • Sandercock AM; MedImmune, Granta Park, Cambridge, CB21 6GH, UK. sandercocka@medimmune.com.
  • Rust S; MedImmune, Granta Park, Cambridge, CB21 6GH, UK. rusts@medimmune.com.
  • Guillard S; MedImmune, Granta Park, Cambridge, CB21 6GH, UK. guillards@medimmune.com.
  • Sachsenmeier KF; MedImmune, One MedImmune Way, Gaithersburg, MD, 20287, USA. sachsenmeierk@medimmune.com.
  • Holoweckyj N; MedImmune, One MedImmune Way, Gaithersburg, MD, 20287, USA. holoweckyjn@medimmune.com.
  • Hay C; MedImmune, One MedImmune Way, Gaithersburg, MD, 20287, USA. hayc@medimmune.com.
  • Flynn M; MedImmune, One MedImmune Way, Gaithersburg, MD, 20287, USA. flynnm@medimmune.com.
  • Huang Q; MedImmune, One MedImmune Way, Gaithersburg, MD, 20287, USA. huangq@MedImmune.com.
  • Yan K; OcellO, Leiden BioPartner Center, J. H Oortweg 21, 2333 CH, Leiden, The Netherlands. Kuan.yan@OcellO.nl.
  • Herpers B; OcellO, Leiden BioPartner Center, J. H Oortweg 21, 2333 CH, Leiden, The Netherlands. Bram.herpers@OcellO.nl.
  • Price LS; OcellO, Leiden BioPartner Center, J. H Oortweg 21, 2333 CH, Leiden, The Netherlands. Leo.price@OcellO.nl.
  • Soden J; Retrogenix, Crown House, Bingswood Estate, Whaley Bridge, High Peak, SK23 7LY, UK. Jo.Soden@retrogenix.com.
  • Freeth J; Retrogenix, Crown House, Bingswood Estate, Whaley Bridge, High Peak, SK23 7LY, UK. Jim.freeth@retrogenix.com.
  • Jermutus L; MedImmune, Granta Park, Cambridge, CB21 6GH, UK. jermutusl@medimmune.com.
  • Hollingsworth R; MedImmune, One MedImmune Way, Gaithersburg, MD, 20287, USA. hollingsworthr@medimmune.com.
  • Minter R; MedImmune, Granta Park, Cambridge, CB21 6GH, UK. minterr@medimmune.com.
Mol Cancer ; 14: 147, 2015 Jul 31.
Article en En | MEDLINE | ID: mdl-26227951
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Ensayos de Selección de Medicamentos Antitumorales / Descubrimiento de Drogas / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Animals / Humans Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Ensayos de Selección de Medicamentos Antitumorales / Descubrimiento de Drogas / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Animals / Humans Idioma: En Año: 2015 Tipo del documento: Article